US Merck Seeks To Upend Pfizer Pneumonia Vaccine Again
Merck Sharp & Dohme Corp. has slapped Pfizer with a lawsuit in the U.K. seeking to invalidate a patent for a new version of its pneumonia vaccine, calling the treatment obvious...To view the full article, register now.
Already a subscriber? Click here to view full article